(Circulation. 2008;118:96-101.)
© 2008 American Heart Association, Inc.
Statistical Primer for Cardiovascular Research |
From the Department of Biostatistics, Boston University School of Public Health, Boston, Mass.
Correspondence to Kathryn L. Lunetta, Department of Biostatistics, Boston University School of Public Health, 715 Albany St, Crosstown Center, 3rd Floor, Boston, MA 02118. E-mail klunetta@bu.edu
Key Words: genetics statistics epidemiology
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| Introduction |
|---|
1 million genetic polymorphisms at once, genetic association studies are becoming more comprehensive. This article first provides a brief overview of the rationale for genetic association studies; it then discusses the primary features differentiating genetic from standard association studies and emphasizes these differences with an example. Finally, this article reviews methods for addressing 2 of the main pitfalls of genetic association studies: population stratification and multiple testing. The principal focus of this primer is population-based association studies using unrelated individuals. A future article will address family-based linkage and association studies.
| Rationale |
|---|
1 genetic polymorphisms and phenotypes or disease states and thus to identify genetic risk factors that can later be studied in a more comprehensive manner using traditional epidemiological methods. Ideally, the statistical analyses brings us to the point where 1 or several genetic variants are identified as the potential functional variants within a gene, so that laboratory scientists can then use experimental methods to determine what functional purpose the variants have and how it might relate to the phenotype. Historically, the term polymorphism has been used to refer to genetic mutations that occur with a frequency
1% in the population. This article refers to genomic locations with multiple alleles interchangeably as genetic variants This article has been cited by other articles:
![]() |
S. Weinsheimer, H. Kim, L. Pawlikowska, Y. Chen, M. T. Lawton, S. Sidney, P.-Y. Kwok, C. E. McCulloch, and W. L. Young EPHB4 Gene Polymorphisms and Risk of Intracranial Hemorrhage in Patients With Brain Arteriovenous Malformations Circ Cardiovasc Genet, October 1, 2009; 2(5): 476 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Barbalic, G. L. Schwartz, A. B. Chapman, S. T. Turner, and E. Boerwinkle Kininogen gene (KNG) variation has a consistent effect on aldosterone response to antihypertensive drug therapy: the GERA study Physiol Genomics, September 1, 2009; 39(1): 56 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ding and I. J. Kullo Genome-wide Association Studies for Atherosclerotic Vascular Disease and Its Risk Factors. Circ Cardiovasc Genet, February 1, 2009; 2: 63 - 72. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |